ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers ...
Insulet has begun a voluntary recall of the remote-control devices used with its Omnipod Dash insulin pumps after discovering that the devices’ batteries may be at risk of swelling, leaking or ...
“We’re thrilled to bring this convenient and easy-to-use insulin delivery system to Canada,” said Bret Christensen, Chief Commercial Officer of Insulet. “The Omnipod DASH System’s sleek, touchscreen ...
The FDA posted a notice saying the recall of Insulet's Omnipod DASH Insulin Management System Personal Diabetes Manager is a Class I, the most serious recall indicating the devices could cause serious ...
Share on Pinterest Image via Insulet Corp. If you’re interested in an insulin pump that is not tethered to your body via tubing, be aware that there’s currently just one choice available to people ...
LONDON–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), ...
ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results